-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Aardvark Therapeutics, Maintains $9 Price Target

Benzinga·03/24/2026 10:59:46
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Aardvark Therapeutics (NASDAQ:AARD) with a Buy and maintains $9 price target.